Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study

Background. The risk factors for the mortality rate of Pneumocystis jirovecii pneumonia (PCP) who required mechanical ventilation (MV) remained unknown. Methods. A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed research international 2017-01, Vol.2017 (2017), p.1-7
Hauptverfasser: Sato, Yoko, Fukuda, Satoshi, Miyazaki, Yuya, Katayama, Shinshu, Kotani, Toru, Ohsugi, Koichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7
container_issue 2017
container_start_page 1
container_title BioMed research international
container_volume 2017
creator Sato, Yoko
Fukuda, Satoshi
Miyazaki, Yuya
Katayama, Shinshu
Kotani, Toru
Ohsugi, Koichi
description Background. The risk factors for the mortality rate of Pneumocystis jirovecii pneumonia (PCP) who required mechanical ventilation (MV) remained unknown. Methods. A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respiratory failure to assess the risk factors for the high mortality. Results. Twenty patients without human immunodeficiency virus infection required mechanical ventilation; 19 received noninvasive ventilation; and 11 were intubated. PEEP was incrementally increased and titrated to maintain FIO2 as low as possible. No mandatory ventilation was used. Sixteen patients (80%) survived. Pneumothorax developed in one patient with rheumatoid arthritis (RA). Median PEEP level in the first 5 days was 10.0 cmH2O and not associated with death. Multivariate analysis showed the association of incidence of interstitial lung disease and increase in serum KL-6 with 90-day mortality. Conclusions. We found MV strategies to prevent pneumothorax including liberal use of noninvasive ventilation, and PEEP titration and disuse of mandatory ventilation may improve mortality in this setting. Underlying disease of interstitial lung disease was a risk factor and KL-6 may be a useful predictor associated with mortality in patients with RA. These findings will need to be validated in larger studies.
doi_str_mv 10.1155/2017/7452604
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5439059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A557302686</galeid><sourcerecordid>A557302686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-2984327ecf3dd4f674e2f18ad1917df8033de9e8842aec6e99e630e1ab3244983</originalsourceid><addsrcrecordid>eNqN0stuEzEUBuARAtGqdMcaWWKDBKG-j4cFUhTRi9RC1UJZWq7nTOMwsVPbkyoPw7viKCEFVnhjy_7028c6VfWS4PeECHFEMamPai6oxPxJtU8Z4SNJOHm6WzO2Vx2mNMNlKCJxI59Xe1QJWXNK96ufVy79QMfG5hAT6kJEeQroIsRsepdXKHTo0sMwD3aVskto5mJYgnVuu-2dQc6jz8GPTs9u0KXJDnxO6Ps0oCu4H1yEFl2AnRrvrOnRTTl1fVHBf0DjQnIMaQE2uyWgiUmAriE6SOg6D-3qRfWsM32Cw-18UH07_vR1cjo6_3JyNhmfj6yQIo9oozijNdiOtS3vSmlAO6JMSxpSt53CjLXQgFKcGrASmgYkw0DMLaOcN4odVB83uYvhdg6tLY-MpteL6OYmrnQwTv994t1U34WlFpw1WDQl4M02IIb7AVLWc5cs9L3xEIakSYN5gwmv1_T1P3QWhuhLeWuFa8FrKR7VnelBO9-Fcq9dh-qxEDXDVCpZ1LuNsuUXU4Ru92SC9bpB9LpB9LZBCn_1Z5k7_LsdCni7AVPnW_Pg_jMOioHOPGrClFCK_QJkf82K</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1900754765</pqid></control><display><type>article</type><title>Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Sato, Yoko ; Fukuda, Satoshi ; Miyazaki, Yuya ; Katayama, Shinshu ; Kotani, Toru ; Ohsugi, Koichi</creator><contributor>Hunfeld, Klaus P.</contributor><creatorcontrib>Sato, Yoko ; Fukuda, Satoshi ; Miyazaki, Yuya ; Katayama, Shinshu ; Kotani, Toru ; Ohsugi, Koichi ; Hunfeld, Klaus P.</creatorcontrib><description>Background. The risk factors for the mortality rate of Pneumocystis jirovecii pneumonia (PCP) who required mechanical ventilation (MV) remained unknown. Methods. A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respiratory failure to assess the risk factors for the high mortality. Results. Twenty patients without human immunodeficiency virus infection required mechanical ventilation; 19 received noninvasive ventilation; and 11 were intubated. PEEP was incrementally increased and titrated to maintain FIO2 as low as possible. No mandatory ventilation was used. Sixteen patients (80%) survived. Pneumothorax developed in one patient with rheumatoid arthritis (RA). Median PEEP level in the first 5 days was 10.0 cmH2O and not associated with death. Multivariate analysis showed the association of incidence of interstitial lung disease and increase in serum KL-6 with 90-day mortality. Conclusions. We found MV strategies to prevent pneumothorax including liberal use of noninvasive ventilation, and PEEP titration and disuse of mandatory ventilation may improve mortality in this setting. Underlying disease of interstitial lung disease was a risk factor and KL-6 may be a useful predictor associated with mortality in patients with RA. These findings will need to be validated in larger studies.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2017/7452604</identifier><identifier>PMID: 28567422</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Artificial respiration ; Biomedical research ; Complications and side effects ; Disease ; Female ; HIV ; Hospitals ; Human immunodeficiency virus ; Humans ; Infections ; Intensive care ; Intubation ; Laboratories ; Male ; Middle Aged ; Mortality ; Mucin-1 - blood ; Mycoses ; Patients ; Pneumocystis carinii ; Pneumonia ; Pneumonia, Pneumocystis - blood ; Pneumonia, Pneumocystis - etiology ; Pneumonia, Pneumocystis - therapy ; Respiration, Artificial ; Respiratory therapy ; Retrospective Studies ; Risk factors</subject><ispartof>BioMed research international, 2017-01, Vol.2017 (2017), p.1-7</ispartof><rights>Copyright © 2017 Toru Kotani et al.</rights><rights>COPYRIGHT 2017 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2017 Toru Kotani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2017 Toru Kotani et al. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-2984327ecf3dd4f674e2f18ad1917df8033de9e8842aec6e99e630e1ab3244983</citedby><cites>FETCH-LOGICAL-c565t-2984327ecf3dd4f674e2f18ad1917df8033de9e8842aec6e99e630e1ab3244983</cites><orcidid>0000-0001-9504-0061</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439059/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439059/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28567422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hunfeld, Klaus P.</contributor><creatorcontrib>Sato, Yoko</creatorcontrib><creatorcontrib>Fukuda, Satoshi</creatorcontrib><creatorcontrib>Miyazaki, Yuya</creatorcontrib><creatorcontrib>Katayama, Shinshu</creatorcontrib><creatorcontrib>Kotani, Toru</creatorcontrib><creatorcontrib>Ohsugi, Koichi</creatorcontrib><title>Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Background. The risk factors for the mortality rate of Pneumocystis jirovecii pneumonia (PCP) who required mechanical ventilation (MV) remained unknown. Methods. A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respiratory failure to assess the risk factors for the high mortality. Results. Twenty patients without human immunodeficiency virus infection required mechanical ventilation; 19 received noninvasive ventilation; and 11 were intubated. PEEP was incrementally increased and titrated to maintain FIO2 as low as possible. No mandatory ventilation was used. Sixteen patients (80%) survived. Pneumothorax developed in one patient with rheumatoid arthritis (RA). Median PEEP level in the first 5 days was 10.0 cmH2O and not associated with death. Multivariate analysis showed the association of incidence of interstitial lung disease and increase in serum KL-6 with 90-day mortality. Conclusions. We found MV strategies to prevent pneumothorax including liberal use of noninvasive ventilation, and PEEP titration and disuse of mandatory ventilation may improve mortality in this setting. Underlying disease of interstitial lung disease was a risk factor and KL-6 may be a useful predictor associated with mortality in patients with RA. These findings will need to be validated in larger studies.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Artificial respiration</subject><subject>Biomedical research</subject><subject>Complications and side effects</subject><subject>Disease</subject><subject>Female</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Intensive care</subject><subject>Intubation</subject><subject>Laboratories</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mucin-1 - blood</subject><subject>Mycoses</subject><subject>Patients</subject><subject>Pneumocystis carinii</subject><subject>Pneumonia</subject><subject>Pneumonia, Pneumocystis - blood</subject><subject>Pneumonia, Pneumocystis - etiology</subject><subject>Pneumonia, Pneumocystis - therapy</subject><subject>Respiration, Artificial</subject><subject>Respiratory therapy</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqN0stuEzEUBuARAtGqdMcaWWKDBKG-j4cFUhTRi9RC1UJZWq7nTOMwsVPbkyoPw7viKCEFVnhjy_7028c6VfWS4PeECHFEMamPai6oxPxJtU8Z4SNJOHm6WzO2Vx2mNMNlKCJxI59Xe1QJWXNK96ufVy79QMfG5hAT6kJEeQroIsRsepdXKHTo0sMwD3aVskto5mJYgnVuu-2dQc6jz8GPTs9u0KXJDnxO6Ps0oCu4H1yEFl2AnRrvrOnRTTl1fVHBf0DjQnIMaQE2uyWgiUmAriE6SOg6D-3qRfWsM32Cw-18UH07_vR1cjo6_3JyNhmfj6yQIo9oozijNdiOtS3vSmlAO6JMSxpSt53CjLXQgFKcGrASmgYkw0DMLaOcN4odVB83uYvhdg6tLY-MpteL6OYmrnQwTv994t1U34WlFpw1WDQl4M02IIb7AVLWc5cs9L3xEIakSYN5gwmv1_T1P3QWhuhLeWuFa8FrKR7VnelBO9-Fcq9dh-qxEDXDVCpZ1LuNsuUXU4Ru92SC9bpB9LpB9LZBCn_1Z5k7_LsdCni7AVPnW_Pg_jMOioHOPGrClFCK_QJkf82K</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Sato, Yoko</creator><creator>Fukuda, Satoshi</creator><creator>Miyazaki, Yuya</creator><creator>Katayama, Shinshu</creator><creator>Kotani, Toru</creator><creator>Ohsugi, Koichi</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9504-0061</orcidid></search><sort><creationdate>20170101</creationdate><title>Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study</title><author>Sato, Yoko ; Fukuda, Satoshi ; Miyazaki, Yuya ; Katayama, Shinshu ; Kotani, Toru ; Ohsugi, Koichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-2984327ecf3dd4f674e2f18ad1917df8033de9e8842aec6e99e630e1ab3244983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Artificial respiration</topic><topic>Biomedical research</topic><topic>Complications and side effects</topic><topic>Disease</topic><topic>Female</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Intensive care</topic><topic>Intubation</topic><topic>Laboratories</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mucin-1 - blood</topic><topic>Mycoses</topic><topic>Patients</topic><topic>Pneumocystis carinii</topic><topic>Pneumonia</topic><topic>Pneumonia, Pneumocystis - blood</topic><topic>Pneumonia, Pneumocystis - etiology</topic><topic>Pneumonia, Pneumocystis - therapy</topic><topic>Respiration, Artificial</topic><topic>Respiratory therapy</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Yoko</creatorcontrib><creatorcontrib>Fukuda, Satoshi</creatorcontrib><creatorcontrib>Miyazaki, Yuya</creatorcontrib><creatorcontrib>Katayama, Shinshu</creatorcontrib><creatorcontrib>Kotani, Toru</creatorcontrib><creatorcontrib>Ohsugi, Koichi</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Yoko</au><au>Fukuda, Satoshi</au><au>Miyazaki, Yuya</au><au>Katayama, Shinshu</au><au>Kotani, Toru</au><au>Ohsugi, Koichi</au><au>Hunfeld, Klaus P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>2017</volume><issue>2017</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Background. The risk factors for the mortality rate of Pneumocystis jirovecii pneumonia (PCP) who required mechanical ventilation (MV) remained unknown. Methods. A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respiratory failure to assess the risk factors for the high mortality. Results. Twenty patients without human immunodeficiency virus infection required mechanical ventilation; 19 received noninvasive ventilation; and 11 were intubated. PEEP was incrementally increased and titrated to maintain FIO2 as low as possible. No mandatory ventilation was used. Sixteen patients (80%) survived. Pneumothorax developed in one patient with rheumatoid arthritis (RA). Median PEEP level in the first 5 days was 10.0 cmH2O and not associated with death. Multivariate analysis showed the association of incidence of interstitial lung disease and increase in serum KL-6 with 90-day mortality. Conclusions. We found MV strategies to prevent pneumothorax including liberal use of noninvasive ventilation, and PEEP titration and disuse of mandatory ventilation may improve mortality in this setting. Underlying disease of interstitial lung disease was a risk factor and KL-6 may be a useful predictor associated with mortality in patients with RA. These findings will need to be validated in larger studies.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>28567422</pmid><doi>10.1155/2017/7452604</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9504-0061</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2017-01, Vol.2017 (2017), p.1-7
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5439059
source MEDLINE; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access
subjects Adult
Aged
Aged, 80 and over
Artificial respiration
Biomedical research
Complications and side effects
Disease
Female
HIV
Hospitals
Human immunodeficiency virus
Humans
Infections
Intensive care
Intubation
Laboratories
Male
Middle Aged
Mortality
Mucin-1 - blood
Mycoses
Patients
Pneumocystis carinii
Pneumonia
Pneumonia, Pneumocystis - blood
Pneumonia, Pneumocystis - etiology
Pneumonia, Pneumocystis - therapy
Respiration, Artificial
Respiratory therapy
Retrospective Studies
Risk factors
title Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T11%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Factors%20for%20the%20Mortality%20of%20Pneumocystis%20jirovecii%20Pneumonia%20in%20Non-HIV%20Patients%20Who%20Required%20Mechanical%20Ventilation:%20A%20Retrospective%20Case%20Series%20Study&rft.jtitle=BioMed%20research%20international&rft.au=Sato,%20Yoko&rft.date=2017-01-01&rft.volume=2017&rft.issue=2017&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2017/7452604&rft_dat=%3Cgale_pubme%3EA557302686%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1900754765&rft_id=info:pmid/28567422&rft_galeid=A557302686&rfr_iscdi=true